107 related articles for article (PubMed ID: 8314937)
1. Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasma.
Kaijser GP; Beijnen JH; Jeunink EL; Bult A; Keizer HJ; de Kraker J; Underberg WJ
J Chromatogr; 1993 May; 614(2):253-9. PubMed ID: 8314937
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
Kurowski V; Wagner T
Cancer Chemother Pharmacol; 1993; 33(1):36-42. PubMed ID: 8269587
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
Huang Z; Waxman DJ
Anal Biochem; 1999 Aug; 273(1):117-25. PubMed ID: 10452807
[TBL] [Abstract][Full Text] [Related]
4. Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels.
Aleksa K; Ito S; Koren G
J Lab Clin Med; 2004 Mar; 143(3):159-62. PubMed ID: 15007305
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and pharmacokinetics of oral and intravenous ifosfamide.
Kurowski V; Cerny T; Küpfer A; Wagner T
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S148-53. PubMed ID: 1795004
[TBL] [Abstract][Full Text] [Related]
6. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
Zaki EL; Springate JE; Taub M
Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
Springate JE
J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo.
Börner K; Kisro J; Brüggemann SK; Hagenah W; Peters SO; Wagner T
Drug Metab Dispos; 2000 May; 28(5):573-6. PubMed ID: 10772637
[TBL] [Abstract][Full Text] [Related]
10. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.
Woodland C; Ito S; Granvil CP; Wainer IW; Klein J; Koren G
Life Sci; 2000 Nov; 68(1):109-17. PubMed ID: 11132240
[TBL] [Abstract][Full Text] [Related]
11. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide.
Dubourg L; Michoudet C; Cochat P; Baverel G
J Am Soc Nephrol; 2001 Aug; 12(8):1615-1623. PubMed ID: 11461933
[TBL] [Abstract][Full Text] [Related]
12. Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde.
Sparidans RW; Veldkamp A; Hoetelmans RM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):115-21. PubMed ID: 10676990
[TBL] [Abstract][Full Text] [Related]
13. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite.
Brüggemann SK; Radike K; Braasch K; Hinrichs J; Kisro J; Hagenah W; Peters SO; Wagner T
Cancer Chemother Pharmacol; 2006 Feb; 57(3):349-56. PubMed ID: 16133533
[TBL] [Abstract][Full Text] [Related]
14. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
Pohl J; Stekar J; Hilgard P
Arzneimittelforschung; 1989 Jun; 39(6):704-5. PubMed ID: 2505783
[TBL] [Abstract][Full Text] [Related]
15. Derivatization-liquid chromatographic assay of chloroacetaldehyde in biological samples.
Ruzicka JA; Ruenitz PC
J Chromatogr; 1990 Oct; 518(2):385-9. PubMed ID: 2254389
[No Abstract] [Full Text] [Related]
16. Analysis of ifosforamide mustard, the active metabolite of ifosfamide, in plasma.
Kaijser GP; Beijnen JH; Rozendom E; Bult A; Underberg WJ
J Chromatogr B Biomed Appl; 1996 Nov; 686(2):249-55. PubMed ID: 8971607
[TBL] [Abstract][Full Text] [Related]
17. Influence of short-term use of dexamethasone on the pharmacokinetics of ifosfamide in patients.
Brüggemann SK; Pfäffle S; Peters SO; Wagner T
Drug Metab Dispos; 2007 Oct; 35(10):1721-4. PubMed ID: 17600085
[TBL] [Abstract][Full Text] [Related]
18. Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography.
Kaijser GP; Ter Riet PG; de Kraker J; Bult A; Beijnen JH; Underberg WJ
J Pharm Biomed Anal; 1997 Mar; 15(6):773-81. PubMed ID: 9172103
[TBL] [Abstract][Full Text] [Related]
19. The analysis of ifosfamide and its metabolites (review).
Kaijser GP; Korst A; Beijnen JH; Bult A; Underberg WJ
Anticancer Res; 1993; 13(5A):1311-24. PubMed ID: 8239501
[TBL] [Abstract][Full Text] [Related]
20. Spectrofluorimetric determination of 2-chloro-2'-deoxyadenosine (cladribine) in human plasma by photochemical reaction and chloroacetaldehyde derivatization.
Gajewska M; Pawiński T; Dzierzgowska-Szmidt A; Kazimierczuk Z
Pharmazie; 1995 Jul; 50(7):459-60. PubMed ID: 7675888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
